Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Why Is Novavax (NVAX) Stock Up 10% Today?

Interest around the potential for another Covid-19 surge this winter, as well as vaccine efficacy, has NVAX stock soaring today.

Lytus Technologies (LYT) Stock Gains 60% After Freefall

On little news over the past week, investors in Lytus Technologies and LYT stock have been on an extremely volatile ride.

Endo International (ENDP) Stock Plunges 20% After Missing Interest Payment

Here's what investors may want to know about today's 20% downside move in ENDO stock, a day after this stock rocketed 90% higher.

FTX, BlockFi News: Sam Bankman-Fried’s FTX Close to Buying Troubled BlockFi for $25 Million

Today, crypto investors may want to closely monitor ongoing deals in the CeFi space, as FTX reaches a deal for BlockFi.

TYDE Stock Alert: 7 Things to Know as Cryptyde Starts Trading Today

For investors in Cryptyde and TYDE stock, today's debut was what could only be described as dismal as shares dropped 60%.